吡咯并咔唑类
产品列表
-
-
11,12-二氢-11-苯基吲哚并[2,3-a]咔唑有现货 货号: D154436查看产品价格与包装
技术标识符
- IUPAC名称
- 12-phenyl-11H-indolo[2,3-a]carbazole
- SMILES
- C1=CC=C(C=C1)N2C3=CC=CC=C3C4=C2C5=C(C=C4)C6=CC=CC=C6N5
- InChIKey
- IENOQUQIVSMWGP-UHFFFAOYSA-N
- InChI
- 1S/C24H16N2/c1-2-8-16(9-3-1)26-22-13-7-5-11-18(22)20-15-14-19-17-10-4-6-12-21(17)25-23(19)24(20)26/h1-15,25H
-
5,11-二氢吲哚并[3,2-b]咔唑有现货 货号: D154424查看产品价格与包装
技术标识符
- IUPAC名称
- 5,11-dihydroindolo[3,2-b]carbazole
- SMILES
- C1=CC=C2C(=C1)C3=CC4=C(C=C3N2)C5=CC=CC=C5N4
- InChIKey
- YCPBCVTUBBBNJJ-UHFFFAOYSA-N
- InChI
- 1S/C18H12N2/c1-3-7-15-11(5-1)13-9-18-14(10-17(13)19-15)12-6-2-4-8-16(12)20-18/h1-10,19-20H
-
KT5823,PKG抑制剂CAS: 126643-37-6 分子式: C29H25N3O5 分子量: 495.5Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。 ≥97%(HPLC)有现货 货号: K139567查看产品价格与包装
技术标识符
- IUPAC名称
- methyl (15S,16R,18R)-16-methoxy-4,15-dimethyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylate
- SMILES
- CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CN(C6=O)C)(C(=O)OC)OC
- InChIKey
- QTYMDECKVKSGSM-YMUMJAELSA-N
- InChI
- 1S/C29H25N3O5/c1-28-29(36-4,27(34)35-3)13-20(37-28)31-18-11-7-5-9-15(18)22-23-17(14-30(2)26(23)33)21-16-10-6-8-12-19(16)32(28)25(21)24(22)31/h5-12,20H,13-14H2,1-4H3/t20-,28+,29+/m1/s1
- 关联靶标
- Muscarinic acetylcholine receptor M2, Muscarinic acetylcholine receptor M1
-
KT5720,蛋白激酶A抑制剂CAS: 108068-98-0 分子式: C32H31N3O5 分子量: 537.6Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。 ≥97%(HPLC)期货 货号: K139563查看产品价格与包装
技术标识符
- IUPAC名称
- hexyl (15R,16S,18S)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylate
- SMILES
- CCCCCCOC(=O)C1(CC2N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N(C7=C53)C1(O2)C)CNC6=O)O
- InChIKey
- ZHEHVZXPFVXKEY-RUAOOFDTSA-N
- InChI
- 显示更多
- 关联靶标
- Muscarinic acetylcholine receptor M4, Muscarinic acetylcholine receptor M1
-
K252b,蛋白激酶抑制剂CAS: 99570-78-2 分子式: C26H19N3O5 分子量: 453.5有现货 货号: K139556查看产品价格与包装
技术标识符
- IUPAC名称
- (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylic acid
- SMILES
- CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(C(=O)O)O
- InChIKey
- AMSOPBXQXSAAAC-PLZPTFKGSA-N
- InChI
- 1S/C26H19N3O5/c1-25-26(33,24(31)32)10-17(34-25)28-15-8-4-2-6-12(15)19-20-14(11-27-23(20)30)18-13-7-3-5-9-16(13)29(25)22(18)21(19)28/h2-9,17,33H,10-11H2,1H3,(H,27,30)(H,31,32)/t17-,25+,26+/m1/s1
-
K-252a,蛋白质和CAM激酶抑制剂有现货 货号: K139531查看产品价格与包装
技术标识符
- IUPAC名称
- methyl (15S,16R,18R)-16-hydroxy-15-methyl-3-oxo-28-oxa-4,14,19-triazaoctacyclo[12.11.2.115,18.02,6.07,27.08,13.019,26.020,25]octacosa-1,6,8,10,12,20,22,24,26-nonaene-16-carboxylate
- SMILES
- CC12C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)(C(=O)OC)O
- InChIKey
- KOZFSFOOLUUIGY-SOLYNIJKSA-N
- InChI
- 1S/C27H21N3O5/c1-26-27(33,25(32)34-2)11-18(35-26)29-16-9-5-3-7-13(16)20-21-15(12-28-24(21)31)19-14-8-4-6-10-17(14)30(26)23(19)22(20)29/h3-10,18,33H,11-12H2,1-2H3,(H,28,31)/t18-,26+,27+/m1/s1
- 关联靶标
- Serine/threonine-protein kinase/endoribonuclease IRE1, Cyclin-dependent kinase 4, Serine/threonine-protein kinase 4, Interleukin-1 receptor-associated kinase 4, TRAF2 and NCK-interacting protein kinase, Serine/threonine-protein kinase Nek7, MAP/microtubule affinity-regulating kinase 4, Mitogen-activated protein kinase kinase kinase kinase 4, Aurora kinase A, Uncharacterized protein FLJ45252, AP2-associated protein kinase 1, 5'-AMP-activated protein kinase subunit gamma-2, Dual specificity protein kinase CLK1, Dual specificity protein kinase CLK4, High affinity nerve growth factor receptor, Myosin light chain kinase, smooth muscle
-
UCN-01,PKC抑制剂Moligand™ ? Moligand™ —— 阿拉丁的配体和生物活性小分子系列。适用于需要明确小分子工具的受体、通路和结合研究。 ≥95%(HPLC)有现货 货号: U138038查看产品价格与包装
技术标识符
- IUPAC名称
- (2S,3R,4R,6R,18R)-18-hydroxy-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
- SMILES
- CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(NC6=O)O)NC)OC
- InChIKey
- PBCZSGKMGDDXIJ-HQCWYSJUSA-N
- InChI
- 显示更多
- 关联靶标
- Cyclin-dependent kinase 1, cAMP-dependent protein kinase type I-alpha regulatory subunit, cAMP-dependent protein kinase type II-alpha regulatory subunit, cAMP-dependent protein kinase catalytic subunit beta, cAMP-dependent protein kinase catalytic subunit gamma, Protein kinase C delta type, Protein kinase C beta type, Protein kinase C epsilon type, Tyrosine-protein kinase Lck, Serine/threonine-protein kinase Chk1, Serine/threonine-protein kinase Chk2, Glycogen synthase kinase-3 beta, cAMP-dependent protein kinase type I-beta regulatory subunit, cAMP-dependent protein kinase type II-beta regulatory subunit, cAMP-dependent protein kinase catalytic subunit alpha, Protein kinase C gamma type, Protein kinase C alpha type, Mitogen-activated protein kinase 14, Serine/threonine-protein kinase MARK1, 3-phosphoinositide-dependent protein kinase 1
-
Stauprimide,抑制剂有现货 货号: S139814查看产品价格与包装
技术标识符
- IUPAC名称
- N-[(2S,3R,4R,6R)-3-methoxy-2-methyl-16,18-dioxo-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-4-yl]-N-methylbenzamide
- SMILES
- CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)C(=O)NC6=O)N(C)C(=O)C9=CC=CC=C9)OC
- InChIKey
- MQCCJEYZKWZQHU-MPRCCEKMSA-N
- InChI
- 显示更多
-
星形孢菌素有现货 货号: S102392查看产品价格与包装
技术标识符
- IUPAC名称
- (2S,3R,4R,6R)-3-methoxy-2-methyl-4-(methylamino)-29-oxa-1,7,17-triazaoctacyclo[12.12.2.12,6.07,28.08,13.015,19.020,27.021,26]nonacosa-8,10,12,14,19,21,23,25,27-nonaen-16-one
- SMILES
- CC12C(C(CC(O1)N3C4=CC=CC=C4C5=C6C(=C7C8=CC=CC=C8N2C7=C53)CNC6=O)NC)OC
- InChIKey
- HKSZLNNOFSGOKW-FYTWVXJKSA-N
- InChI
- 1S/C28H26N4O3/c1-28-26(34-3)17(29-2)12-20(35-28)31-18-10-6-4-8-14(18)22-23-16(13-30-27(23)33)21-15-9-5-7-11-19(15)32(28)25(21)24(22)31/h4-11,17,20,26,29H,12-13H2,1-3H3,(H,30,33)/t17-,20-,26-,28+/m1/s1
- 关联靶标
- Cyclin-dependent kinase 1, Peripheral plasma membrane protein CASK, Tyrosine-protein kinase CSK, Serine/threonine-protein kinase/endoribonuclease IRE2, Serine/threonine-protein kinase/endoribonuclease IRE1, Ephrin type-A receptor 4, Ephrin type-B receptor 1, Receptor tyrosine-protein kinase erbB-4, Ephrin type-A receptor 5, Receptor tyrosine-protein kinase erbB-2, Dual specificity tyrosine-phosphorylation-regulated kinase 1B, Dual specificity tyrosine-phosphorylation-regulated kinase 3, eIF-2-alpha kinase GCN2, Myotonin-protein kinase, Dual specificity tyrosine-phosphorylation-regulated kinase 1A, Discoidin domain-containing receptor 2, Dual serine/threonine and tyrosine protein kinase, Epidermal growth factor receptor, Focal adhesion kinase 1, Ephrin type-A receptor 3, Macrophage colony-stimulating factor 1 receptor, Casein kinase II subunit alpha', Death-associated protein kinase 3, Cyclin-dependent kinase 16, Cyclin-dependent kinase 4, Serine/threonine-protein kinase DCLK3, Cyclin-dependent kinase 2, Death-associated protein kinase 2, Epithelial discoidin domain-containing receptor 1, Death-associated protein kinase 1, Proto-oncogene tyrosine-protein kinase receptor Ret, Retinoblastoma-associated protein, Protein odd-skipped-related 1, Serine/threonine-protein kinase PAK 5, cAMP-dependent protein kinase catalytic subunit PRKX, Rhodopsin kinase, Serine/threonine-protein kinase Sgk2, SRSF protein kinase 1, Serine/threonine-protein kinase Sgk1, Serine/threonine-protein kinase Sgk3, Proto-oncogene tyrosine-protein kinase Src, Rho-associated protein kinase 2, Serine/threonine-protein kinase SBK1, Lysine--tRNA ligase, Uncharacterized serine/threonine-protein kinase SBK3, Rho-associated protein kinase 1, Proto-oncogene tyrosine-protein kinase ROS, Serine/threonine-protein kinase 17A, Serine/threonine-protein kinase 38-like, Serine/threonine-protein kinase 25, Serine/threonine-protein kinase 26, Serine/threonine-protein kinase 10, Serine/threonine-protein kinase 33, STE20/SPS1-related proline-alanine-rich protein kinase, Serine/threonine-protein kinase 3, Serine/threonine-protein kinase 17B, Serine/threonine-protein kinase 32B, Serine/threonine-protein kinase 24, Serine/threonine-protein kinase 38, Serine/threonine-protein kinase 4, Tyrosine-protein kinase TXK, Vascular endothelial growth factor receptor 3, Tyrosine-protein kinase Yes, Tyrosine-protein kinase receptor TYRO3, Non-receptor tyrosine-protein kinase TYK2, Interleukin-1 receptor-associated kinase 4, Serine/threonine-protein kinase ICK, Interleukin-1 receptor-associated kinase 1, Inhibitor of nuclear factor kappa-B kinase subunit epsilon, Inhibitor of nuclear factor kappa-B kinase subunit alpha, Inhibitor of nuclear factor kappa-B kinase subunit beta, Tyrosine-protein kinase FRK, Tyrosine-protein kinase Fyn, Ephrin type-A receptor 6, Serine/threonine-protein kinase haspin, Calcium/calmodulin-dependent protein kinase kinase 2, Tyrosine-protein kinase Fer, Receptor-type tyrosine-protein kinase FLT3, Cyclin-G-associated kinase, Fibroblast growth factor receptor 1, Fibroblast growth factor receptor 2, Tyrosine-protein kinase Fes/Fps, Protein-tyrosine kinase 2-beta, Fibroblast growth factor receptor 3, Tyrosine-protein kinase Fgr, Glucokinase, Homeodomain-interacting protein kinase 1, Interleukin-1 receptor-associated kinase 3, Calcium/calmodulin-dependent protein kinase type 1B, Calcium/calmodulin-dependent protein kinase type 1D, Calcium/calmodulin-dependent protein kinase type 1G, Insulin-like growth factor 1 receptor, Maternal embryonic leucine zipper kinase, Tyrosine-protein kinase ITK/TSK, Tyrosine-protein kinase JAK3, cAMP-dependent protein kinase catalytic subunit beta, cAMP-dependent protein kinase catalytic subunit gamma, Calcium/calmodulin-dependent protein kinase type II subunit beta, Tyrosine-protein kinase Mer, Testis-specific serine/threonine-protein kinase 1, Thioredoxin reductase 1, cytoplasmic, Serine/threonine-protein kinase tousled-like 2, SNF-related serine/threonine-protein kinase, Non-receptor tyrosine-protein kinase TNK1, Serine/threonine-protein kinase SIK1, Serine/threonine-protein kinase SIK2, TRAF2 and NCK-interacting protein kinase, Serine/threonine-protein kinase TBK1, Serine/threonine-protein kinase TAO1, Tyrosine-protein kinase Tec, Serine/threonine-protein kinase TAO2, Serine/threonine-protein kinase TAO3, Serine/threonine-protein kinase tousled-like 1, Serine/threonine-protein kinase SIK3, STE20-like serine/threonine-protein kinase, Testis-specific serine/threonine-protein kinase 2, Testis-specific serine/threonine-protein kinase 3, Serine/threonine-protein kinase PLK4, Serine/threonine-protein kinase pim-1, Serine/threonine-protein kinase N3, Serine/threonine-protein kinase N1, Platelet-derived growth factor receptor alpha, Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform, Serine/threonine-protein kinase pim-2, Serine/threonine-protein kinase pim-3, Phosphorylase b kinase gamma catalytic chain, liver/testis isoform, Platelet-derived growth factor receptor beta, [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial, Inactive tyrosine-protein kinase PEAK1, Serine/threonine-protein kinase N2, cGMP-dependent protein kinase 1, Ribosomal protein S6 kinase beta-1, Misshapen-like kinase 1, MAP kinase-interacting serine/threonine-protein kinase 2, Serine/threonine-protein kinase LATS1, cGMP-dependent protein kinase 2, Protein kinase C delta type, Ribosomal protein S6 kinase alpha-1, Ribosomal protein S6 kinase alpha-2, Tyrosine-protein kinase SYK, Protein kinase C beta type, Serine/threonine-protein kinase D2, Protein kinase C epsilon type, Ribosomal protein S6 kinase alpha-6, Mitogen-activated protein kinase 15, Serine/threonine-protein kinase LATS2, Protein kinase C eta type, Ribosomal protein S6 kinase alpha-5, Serine/threonine-protein kinase D1, Protein kinase C iota type, Mitogen-activated protein kinase kinase kinase 15, Serine/threonine-protein kinase MARK2, Dual specificity mitogen-activated protein kinase kinase 2, Dual specificity mitogen-activated protein kinase kinase 3, Mitogen-activated protein kinase kinase kinase kinase 2, Serine/threonine-protein kinase Nek8, LIM domain kinase 1, Mitogen-activated protein kinase kinase kinase 19, Mitogen-activated protein kinase kinase kinase 10, Tyrosine-protein kinase Lck, Leukocyte tyrosine kinase receptor, Mitogen-activated protein kinase kinase kinase 12, Mitogen-activated protein kinase kinase kinase kinase 1, MAP/microtubule affinity-regulating kinase 3, MAP/microtubule affinity-regulating kinase 4, Mitogen-activated protein kinase kinase kinase kinase 3, Leucine-rich repeat serine/threonine-protein kinase 2, Serine/threonine-protein kinase Nek1, Mitogen-activated protein kinase kinase kinase kinase 4, Mitogen-activated protein kinase kinase kinase kinase 5, Mitogen-activated protein kinase kinase kinase 11, Mitogen-activated protein kinase kinase kinase 2, Mitogen-activated protein kinase kinase kinase 3, Serine/threonine-protein kinase MAK, Dual specificity mitogen-activated protein kinase kinase 6, Tyrosine-protein kinase JAK1, Serine/threonine-protein kinase MRCK alpha, Tyrosine-protein kinase Lyn, Mitogen-activated protein kinase kinase kinase 5, Dual specificity mitogen-activated protein kinase kinase 4, Cytochrome P450 11B2, mitochondrial, BMP-2-inducible protein kinase, Serine/threonine-protein kinase B-raf, Serine/threonine-protein kinase BRSK2, Tyrosine-protein kinase BTK, Serine/threonine-protein kinase BRSK1, Cytoplasmic tyrosine-protein kinase BMX, Tyrosine-protein kinase Blk, Aurora kinase A, Aurora kinase B, Aurora kinase C, Cyclin-dependent kinase 3, Tyrosine-protein kinase ZAP-70, Vascular endothelial growth factor receptor 1, Vascular endothelial growth factor receptor 2, AP2-associated protein kinase 1, Activated CDC42 kinase 1, Muscarinic acetylcholine receptor M4, Muscarinic acetylcholine receptor M2, Tyrosine-protein kinase ABL2, Tyrosine-protein kinase ABL1, RAC-gamma serine/threonine-protein kinase, Muscarinic acetylcholine receptor M1, ALK tyrosine kinase receptor, RAC-beta serine/threonine-protein kinase, RAC-alpha serine/threonine-protein kinase, 5'-AMP-activated protein kinase catalytic subunit alpha-1, 5'-AMP-activated protein kinase catalytic subunit alpha-2, Serine/threonine-protein kinase Chk1, Serine/threonine-protein kinase Chk2, Serine/threonine-protein kinase 32A, Tyrosine-protein kinase receptor UFO, Serine/threonine-protein kinase ULK1, Serine/threonine-protein kinase ULK2, Serine/threonine-protein kinase ULK3, Dual specificity protein kinase CLK1, Dual specificity protein kinase CLK2, Dual specificity protein kinase CLK4, Glycogen synthase kinase-3 beta, Glycogen synthase kinase-3 alpha, Tyrosine-protein kinase HCK, Mast/stem cell growth factor receptor Kit, Calcium/calmodulin-dependent protein kinase kinase 1, G protein-coupled receptor kinase 5, Insulin receptor-related protein, Insulin receptor, NUAK family SNF1-like kinase 2, Serine/threonine-protein kinase PAK 4, Serine/threonine-protein kinase PAK 6, PAS domain-containing serine/threonine-protein kinase, Serine/threonine-protein kinase PAK 1, Serine/threonine-protein kinase PAK 2, Serine/threonine-protein kinase PAK 3, NUAK family SNF1-like kinase 1, Myosin light chain kinase 2, skeletal/cardiac muscle, BDNF/NT-3 growth factors receptor, High affinity nerve growth factor receptor, NT-3 growth factor receptor, NADPH oxidase 4, Calcium/calmodulin-dependent protein kinase type 1, Calcium/calmodulin-dependent protein kinase type II subunit alpha, Calcium/calmodulin-dependent protein kinase type II subunit delta, Calcium/calmodulin-dependent protein kinase type II subunit gamma, Tyrosine-protein kinase JAK2, cAMP-dependent protein kinase catalytic subunit alpha, Protein kinase C gamma type, Protein kinase C alpha type, Ribosomal protein S6 kinase beta-2, Mitogen-activated protein kinase 1, Mitogen-activated protein kinase 14, Protein kinase C theta type, Ribosomal protein S6 kinase alpha-3, Ribosomal protein S6 kinase alpha-4, Serine/threonine-protein kinase D3, Mitogen-activated protein kinase kinase kinase 9, Serine/threonine-protein kinase MARK1, Serine/threonine-protein kinase MRCK beta, Serine/threonine-protein kinase MRCK gamma, Dual specificity mitogen-activated protein kinase kinase 1, Dual specificity mitogen-activated protein kinase kinase 5, Myosin-IIIb, Muscle, skeletal receptor tyrosine-protein kinase, Myosin light chain kinase, smooth muscle, 3-phosphoinositide-dependent protein kinase 1
快速发货
现货产品当日发货
技术详情
每个产品页均提供质量和规格信息
多种规格
多种包装规格和价格可选
仅供科研
产品仅供研发使用
![11,12-二氢吲哚并[2,3-a]咔唑](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/1/D154449.jpg)
![11,12-二氢-11-苯基吲哚并[2,3-a]咔唑](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/1/D154436.png)
![5,11-二氢吲哚并[3,2-b]咔唑](https://www.aladdin-e.com/media/catalog/product/cache/16359f9c8ddfa823fcb5503b1e11b7ae/D/1/D154424.png)







危险品化学品经营许可证(带存储)